Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Martin Mittelstaedt
|
| gptkbp:city |
gptkb:Hamburg
|
| gptkbp:country |
gptkb:Germany
|
| gptkbp:focus |
autoimmune diseases
allergic diseases immune tolerance therapies |
| gptkbp:founded |
2016
|
| https://www.w3.org/2000/01/rdf-schema#label |
Topas Therapeutics
|
| gptkbp:parentCompany |
gptkb:Evotec
|
| gptkbp:technology |
antigen-specific immune tolerance
|
| gptkbp:type |
gptkb:public_company
|
| gptkbp:website |
https://www.topas-therapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Cord_Dohrmann
|
| gptkbp:bfsLayer |
8
|